» Articles » PMID: 36237188

Related Factors Based on Non-targeted Metabolomics Methods in Minor Ischaemic Stroke

Overview
Specialty Endocrinology
Date 2022 Oct 14
PMID 36237188
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to identify potential biomarkers associated with the occurrence of minor ischaemic stroke.

Methods: Four hundred patients hospitalized with minor ischaemic stroke were enrolled in the department of neurological internal medicine in Taiyuan Central Hospital, and 210 healthy subjects examined at the Taiyuan Central Hospital Medical Center during the same period were selected. We collected information on the general demographic characteristics and fasting blood samples of the subjects. We then used untargeted metabolomic assay to measure blood glucose, blood lipids, homocysteine, and high-sensitivity C-reactive protein.

Results: There were statistically significant differences between the mild ischemic stroke group and the healthy control group in smoking, hypertension, and physical activity (P< 0.05). Compared with the healthy group, the minor ischaemic stroke group showed increased lactate, pyruvate, trimetlylamine oxide levels, and lactic acid, pyruvic acid, and trimethylamine N-oxidation (TMAO) levels were statistically significant (P< 0.001). In the minor ischaemic stroke risk model, hypertension, physical activity, smoking, and elevated TMAO levels influenced the occurrence of minor stroke.

Conclusion: Increased levels of lactic acid, pyruvate, and TMAO may be related to the pathophysiological changes in the minor ischaemic stroke population. High blood pressure, a lack of physical activity, smoking, and increased TMAO level were the influencing factors for the occurrence of minor ischaemic stroke. The serum metabolite TMAO may be associated with MS occurrence.

Citing Articles

Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities.

Jaworska K, Kopacz W, Koper M, Ufnal M Int J Mol Sci. 2024; 25(23).

PMID: 39684223 PMC: 11641139. DOI: 10.3390/ijms252312511.


Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke.

Li Z, He X, Fang Q, Yin X Biomolecules. 2024; 14(11).

PMID: 39595639 PMC: 11591650. DOI: 10.3390/biom14111463.


Metabolomic discoveries for early diagnosis and traditional Chinese medicine efficacy in ischemic stroke.

Wei L, Chen S, Deng X, Liu Y, Wang H, Gao X Biomark Res. 2024; 12(1):63.

PMID: 38902829 PMC: 11188286. DOI: 10.1186/s40364-024-00608-7.


Effect of TMAO on the incidence and prognosis of cerebral infarction: a systematic review and meta-analysis.

Wang L, Nan Y, Zhu W, Wang S Front Neurol. 2024; 14:1287928.

PMID: 38259655 PMC: 10801906. DOI: 10.3389/fneur.2023.1287928.


Metabolomic signature between diabetic and non-diabetic obese patients: A protocol for systematic review.

Tai Y, Yang X, Gang X, Cong Z, Wang S, Li P PLoS One. 2024; 19(1):e0296749.

PMID: 38232103 PMC: 10793882. DOI: 10.1371/journal.pone.0296749.


References
1.
Yeh P, Yang C, Lin S, Wang W, Chen P, Chao T . Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study. Atherosclerosis. 2013; 228(2):472-7. DOI: 10.1016/j.atherosclerosis.2013.03.015. View

2.
Ihle-Hansen H, Thommessen B, Wyller T, Engedal K, Fure B . Risk factors for and incidence of subtypes of ischemic stroke. Funct Neurol. 2012; 27(1):35-40. PMC: 3812758. View

3.
Dangour A, Whitehouse P, Rafferty K, Mitchell S, Smith L, Hawkesworth S . B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J Alzheimers Dis. 2010; 22(1):205-24. DOI: 10.3233/JAD-2010-090940. View

4.
Diao C, Zhao L, Guan M, Zheng Y, Chen M, Yang Y . Systemic and characteristic metabolites in the serum of streptozotocin-induced diabetic rats at different stages as revealed by a (1)H-NMR based metabonomic approach. Mol Biosyst. 2014; 10(3):686-93. DOI: 10.1039/c3mb70609e. View

5.
Hindy G, Engstrom G, Larsson S, Traylor M, Markus H, Melander O . Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study. Stroke. 2018; 49(4):820-827. PMC: 5895121. DOI: 10.1161/STROKEAHA.117.019653. View